Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
2026
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.17M | ﹤0.01% |
85,361
+34,681
| +68% | +$1.02M |
|
2027
Coastal Financial
CCB
$672M
| $2.17M | ﹤0.01% |
68,174
+8,700
| +15% | +$259K |
|
2028
Silicom
SILC
$267M
| $2.17M | ﹤0.01% |
50,200
-21,600
| -30% | -$932K |
|
2029
Gogo Inc
GOGO
$626M
| $2.17M | ﹤0.01% |
125,368
+103,934
| +485% | +$1.26M |
|
|
JBGS
2030
JBG SMITH
JBGS
$691M
| $2.17M | ﹤0.01% |
73,200
-249,700
| -77% | -$7.71M |
|
|
TEN
2031
Tsakos Energy Navigation Ltd
TEN
$1.17B
| $2.17M | ﹤0.01% |
202,380
-153,215
| -43% | -$1.21M |
|
|
SMTS
2032
DELISTED
Sierra Metals Inc. Common Stock
SMTS
| $2.16M | ﹤0.01% |
1,201,172
-47,728
| -4% | -$118K |
|
2033
Pulmatrix
PULM
$6.17M
| $2.15M | ﹤0.01% |
134,658
-7,762
| -5% | -$130K |
|
2034
Vanguard FTSE Pacific ETF
VPL
$8.37B
| $2.15M | ﹤0.01% |
26,500
+6,600
| +33% | +$544K |
|
2035
APA Corp
APA
$12.6B
| $2.15M | ﹤0.01% |
100,116
-1,685,938
| -94% | -$32.2M |
|
2036
Eversource Energy
ES
$27.4B
| $2.14M | ﹤0.01% |
26,200
-16,180
| -38% | -$1.4M |
|
2037
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.6B
| $2.14M | ﹤0.01% |
16,000
-1,000
| -6% | -$138K |
|
|
KYNB
2038
Kyntra Bio
KYNB
$28.3M
| $2.13M | ﹤0.01% |
+8,346
| New | +$2.96M |
|
2039
Lisata Therapeutics
LSTA
$10.8M
| $2.13M | ﹤0.01% |
116,470
+12,281
| +12% | +$241K |
|
2040
Cocrystal Pharma
COCP
$13.9M
| $2.13M | ﹤0.01% |
168,897
-47,264
| -22% | -$625K |
|
2041
Cohu
COHU
$2.5B
| $2.12M | ﹤0.01% |
66,354
+24,030
| +57% | +$818K |
|
2042
Heritage Insurance Holdings
HRTG
$905M
| $2.12M | ﹤0.01% |
310,731
-55,068
| -15% | -$396K |
|
2043
Northern Technologies International Corp
NTIC
$81.3M
| $2.11M | ﹤0.01% |
138,977
-6,100
| -4% | -$109K |
|
2044
First United
FUNC
$288M
| $2.11M | ﹤0.01% |
113,495
-25,000
| -18% | -$444K |
|
2045
Tractor Supply
TSCO
$17.4B
| $2.11M | ﹤0.01% |
52,000
-930,000
| -95% | -$36.1M |
|
2046
Stoke Therapeutics
STOK
$1.97B
| $2.11M | ﹤0.01% |
82,800
+1,500
| +2% | +$41.8K |
|
2047
Verastem
VSTM
$512M
| $2.1M | ﹤0.01% |
56,933
+16,508
| +41% | +$606K |
|
2048
Alico
ALCO
$284M
| $2.1M | ﹤0.01% |
61,396
-23,700
| -28% | -$854K |
|
2049
Schwab US Mid-Cap ETF
SCHM
$15.1B
| $2.09M | ﹤0.01% |
81,900
+15,300
| +23% | +$400K |
|
2050
Coffee Holding Co
JVA
$19.5M
| $2.09M | ﹤0.01% |
459,744
+3,000
| +0.7% | +$15.3K |
|
Similar funds
Renaissance Technologies's Q3 2021 Portfolio in Review
As of Q3 2021, Renaissance Technologies held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Renaissance Technologies's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Renaissance Technologies added most to Nike in Q3 2021, an estimated $453M increase.
- Renaissance Technologies's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Renaissance Technologies fully exited Amazon in Q3 2021, selling an estimated $897M.
- Renaissance Technologies's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Renaissance Technologies opened 663 new positions and closed 653 in Q3 2021.
- Renaissance Technologies's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.